Conditions: Hepatitis C Liver Cirrhosis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 2
Healthy volunteers: no

Brief summary:
This trial was intended to investigate the pharmacokinetics, safety and tolerability of BI 201335 NA soft-gel capsules in patients with compensated liver cirrhosis, i.e. grade A according to Child-Pugh classification (\< 7 points).

Detailed description:

Arms:
arm 1: BI 201335 two single oral doses, separated by 14 days washout period

Interventions: intervention 1: BI 201335
Intervention descriptions: intervention 1: single oral doses

Protocol document: